SYNLOGIC, INC. - FORM 8-K - EX-16.1 - August 28, 2017

Attached files

file filename
EX-99.1 - EX-99.1 - SYNLOGIC, INC.d431294dex991.htm
EX-14.1 - EX-14.1 - SYNLOGIC, INC.d431294dex141.htm
EX-10.15 - EX-10.15 - SYNLOGIC, INC.d431294dex1015.htm
EX-10.14 - EX-10.14 - SYNLOGIC, INC.d431294dex1014.htm
EX-10.13 - EX-10.13 - SYNLOGIC, INC.d431294dex1013.htm
EX-10.12 - EX-10.12 - SYNLOGIC, INC.d431294dex1012.htm
EX-10.11 - EX-10.11 - SYNLOGIC, INC.d431294dex1011.htm
EX-10.10 - EX-10.10 - SYNLOGIC, INC.d431294dex1010.htm
EX-10.9 - EX-10.9 - SYNLOGIC, INC.d431294dex109.htm
EX-10.8 - EX-10.8 - SYNLOGIC, INC.d431294dex108.htm
EX-10.7 - EX-10.7 - SYNLOGIC, INC.d431294dex107.htm
EX-10.6 - EX-10.6 - SYNLOGIC, INC.d431294dex106.htm
EX-10.5 - EX-10.5 - SYNLOGIC, INC.d431294dex105.htm
EX-10.4 - EX-10.4 - SYNLOGIC, INC.d431294dex104.htm
EX-10.3 - EX-10.3 - SYNLOGIC, INC.d431294dex103.htm
EX-10.2 - EX-10.2 - SYNLOGIC, INC.d431294dex102.htm
EX-3.2 - EX-3.2 - SYNLOGIC, INC.d431294dex32.htm
EX-3.1 - EX-3.1 - SYNLOGIC, INC.d431294dex31.htm
8-K - 8-K - SYNLOGIC, INC.d431294d8k.htm

Exhibit 16.1

August 28, 2017

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

Ladies and Gentlemen:

We have read Item 4.01 of Form 8-K dated August 28, 2017, of Mirna Therapeutics, Inc. and are in agreement with the statements contained in the second and third paragraphs on page 2 therein. We have no basis to agree or disagree with other statements of the registrant contained therein.

/s/ Ernst and Young LLP

SYNLOGIC, INC. Reports